Cornea/External Disease News

More than half of patients with type 2 diabetic nephropathy had dry eye disease, which was independently associated with older age, high HbA1C and reduced glomerular filtration rate, according to research conducted in Vietnam.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, John D. Sheppard, MD, MMSc, FACS, discusses a post hoc analysis investigating Miebo for the treatment of dry eye disease at different levels of severity.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Neda Gioia, OD, CNS, FOWNS, discusses two studies investigating a novel oral supplement from Bausch + Lomb for patients with dry eye disease.

SEATTLE — In this Healio Video Perspective from the ARVO meeting, Eric D. Donnenfeld, MD, discusses research that investigated Blink Triple Care artificial tears for the treatment of dry eye disease.

Ocular surface disease must be addressed before cataract surgery to ensure patient satisfaction and good surgical outcomes, according to a presentation at Real World Ophthalmology.

Subject dosing is complete in a phase 1/2 clinical trial of an allogeneic cell therapy for the treatment of corneal edema secondary to corneal endothelial dysfunction, according to a press release.

The FDA has approved Lumify Preservative Free eye drops for the treatment of ocular redness due to minor eye irritations, according to a press release from manufacturer Bausch + Lomb.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, Abu Abraham, MD, of Cloudbreak Pharma, and John A. Hovanesian, MD, FACS, discuss developments in the treatment of pterygium.

April is STD Awareness Month, and according to a statement from the U.S. Department of Health and Human Services, STD cases remain high among all demographic groups.

BOSTON — In this Healio Video Perspective from the ASCRS meeting, John Sheets, PhD, of Pantheon Vision previews a product designed to address unmet needs in corneal blindness compared with the standard of care of transplantation.